KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $106.43 million. The enterprise value is $98.87 million.

Market Cap	106.43M
Enterprise Value	98.87M

Important Dates

The last earnings date was Wednesday, April 15, 2026, after market close.

Earnings Date	Apr 15, 2026
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 929.49 million shares outstanding. The number of shares has increased by 114.65% in one year.

Current Share Class	929.49M
Shares Outstanding	929.49M
Shares Change (YoY)	+114.65%
Shares Change (QoQ)	+80.11%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	0.76%
Float	929.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.46
P/TBV Ratio	15.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81

Current Ratio	3.81
Quick Ratio	3.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-12.95

Financial Efficiency

Return on equity (ROE) is -279.18% and return on invested capital (ROIC) is -102.77%.

Return on Equity (ROE)	-279.18%
Return on Assets (ROA)	-81.59%
Return on Invested Capital (ROIC)	-102.77%
Return on Capital Employed (ROCE)	-606.19%
Weighted Average Cost of Capital (WACC)	-6.72%
Revenue Per Employee	n/a
Profits Per Employee	-$4.50M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.40% in the last 52 weeks. The beta is -1.99, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-1.99
52-Week Price Change	-96.40%
50-Day Moving Average	0.25
200-Day Moving Average	3.38
Relative Strength Index (RSI)	26.64
Average Volume (20 Days)	3,507,545

Short Selling Information

The latest short interest is 1.06 million, so 0.11% of the outstanding shares have been sold short.

Short Interest	1.06M
Short Previous Month	1.14M
Short % of Shares Out	0.11%
Short % of Float	0.11%
Short Ratio (days to cover)	0.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-42.41M
Pretax Income	-26.98M
Net Income	-26.98M
EBITDA	-42.09M
EBIT	-42.41M
Earnings Per Share (EPS)	-$3.31

Full Income Statement

Balance Sheet

The company has $7.56 million in cash and n/a in debt, giving a net cash position of $7.56 million or $0.01 per share.

Cash & Cash Equivalents	7.56M
Total Debt	n/a
Net Cash	7.56M
Net Cash Per Share	$0.01
Equity (Book Value)	7.00M
Book Value Per Share	0.25
Working Capital	7.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$31.99 million and capital expenditures -$15,000, giving a free cash flow of -$32.01 million.

Operating Cash Flow	-31.99M
Capital Expenditures	-15,000
Depreciation & Amortization	317,000
Net Borrowing	-22.51M
Free Cash Flow	-32.01M
FCF Per Share	-$0.03

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-114.65%
Shareholder Yield	-114.65%
Earnings Yield	-25.35%
FCF Yield	-30.07%

Analyst Forecast

The average price target for KALA BIO is $31.50, which is 27,410.92% higher than the current price. The consensus rating is "Buy".

Price Target	$31.50
Price Target Difference	27,410.92%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Altman Z-Score	n/a
Piotroski F-Score	1